Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has agreed to issue bonds with an aggregate principal amount of USD 1.5 billion across two tranches.
Dialysis care in China.
A Smart Companion helps an active lifestyle.
In the COVID-19-pandemic, our employees have become true heroes.
Overcoming challenges and seizing opportunities
Time to Think: CEO Rice Powell reflects on a challenging year.
Watch the journey of our home dialysis patient Annalese and find out how she and our employee Matt became friends.
Our strategy until 2025.
Speech of CEO Rice Powell
Digital progress for more time with patients.
February 23, 2021
February 20, 2020